AMN Healthcare price target raised to $24 from $22 at Citizens

Citizens analyst Constantine Davides raised the firm’s price target on AMN Healthcare (AMN) to $24 from $22 and keeps an Outperform rating on the shares. AMN Healthcare may deserve increased recognition for its differentiated ability to deliver large-scale labor disruption staffing, a capability few competitors can match, the analyst tells investors in a research note. Despite near-term strike-related financial impacts, early signs of industry stabilization support a return to normalized growth in 2027, and retention of the Kaiser contract appears likely given the longstanding relationship and recent strike support, the firm says.